| abstract |
A transdermal medication delivery device ( 20 ) for the remote controlled administration of medications ( 68, 70, 72 ) for absorption through the skin of a patient ( 22 ) includes a tubes ( 62 ) containing the medications ( 68, 70, 72 ). Tubes ( 62 ) are in fluid communication with valve inlets ( 76, 82, 88 ) of valves ( 74, 80, 86 ) formed on a micro-electro-mechanical-system-based (MEMS-based) valve chip ( 64, 162 ). A medication delivery component ( 26, 176 ) in fluid communication with valve outlets ( 78, 84, 90 ) of valves ( 74, 80, 86 ) has a surface ( 66, 178 ) adapted to be in contact with the skin of the patient ( 22 ) when in use. A controller ( 92 ) is configured to control a flow of the medications ( 68, 70, 72 ) through the valves ( 74, 80, 86 ), and a wireless communication interface ( 94 ), in communication with the controller ( 92 ), is configured to receive a medication control message ( 96 ) from a remote location ( 32 ). The medication control message ( 96 ) instructs the controller ( 92 ) to regulate the valves ( 74, 80, 86 ) to adjust the flow of the medications ( 68, 70, 72 ) from the tubes ( 62 ) to the surface ( 66, 188 ) of the medication delivery component ( 26, 176 ). |